# NORTHWESTERN UNIVERSITY: A PHASE 2A TRIAL OF IMMUNE MODULATION IN COMBINATION WITH ULTRASOUND-MEDIATED BLOOD BRAIN BARRIER OPENING IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | NORTHWESTERN UNIVERSITY |
| Location | CHICAGO, IL |
| Project | A PHASE 2A TRIAL OF IMMUNE MODULATION IN COMBINATION WITH ULTRASOUND-MEDIATED BLOOD BRAIN BARRIER OPENING IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA |
| Project number | 2R01CA245969-06A1 |
| Mechanism | R01 |
| Institute | National Cancer Institute |
| Award | $548,724 |
| Awarded | 2026-09-17 |
| Project period | 2020-09-10 to 2031-08-31 |
| UEI | KG76WYENL5K1 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11391736). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.